Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in LFCR — Lifecore Biomedical, Inc. De

CIK 19617 NEW YORK, NY
Back to LFCR Full portfolio

Position in LFCR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$88,530
+$31,072 QoQ
Shares Held
16,863
+9.2% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 98 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 30% Shared 0% None 70%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. LFCR ranks #42 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 6,398,674 $1,078,432,506
2 TEVA
Teva Pharmaceutical Industries Ltd
 6,981,234 $236,524,202
3 ZTS
Zoetis Inc.
 2,624,825 $188,619,917
4 HIMS
Hims & Hers Health, Inc.
 4,766,781 $165,264,292
5 UTHR
UNITED THERAPEUTICS Corp
 275,358 $149,197,220
6 VTRS
Viatris Inc
 7,322,267 $116,277,595
7 HLN
Haleon plc
 10,824,395 $100,991,599
8 LNTH
Lantheus Holdings, Inc.
 699,229 $77,572,458

All Filings in LFCR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $88,530 16,863
2026-03-31 $57,458 15,446
2025-12-31 $124,507 15,221
2025-09-30 $90,556 12,304
2025-06-30 $113,606 13,991
2025-03-31 $96,003 13,637
2024-12-31 $87,561 11,785
2024-09-30 $56,181 11,396
2024-06-30 $52,817 10,296
2024-03-31 $17,866 3,365
2023-12-31 $8,932 1,443
2023-09-30 $10,463 1,386
2023-06-30 $10,946 1,132
2023-03-31 $75,868 20,071
2022-12-31 $122,742 18,942
2022-09-30 $127,278 14,317
2022-06-30 $139,659 14,008
2022-03-31 $142,028 12,265
2021-12-31 $344,532 31,039
2021-09-30 $536,463 58,185
2021-06-30 $1,127,766 100,246
2021-03-31 $1,235,555 116,562
2020-12-31 $802,128 73,929
2020-09-30 $146,771 15,100
2020-06-30 $165,081 20,739
2020-03-31 $73,847 8,498